The wait for the new USPTO 101 guidance is over
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The wait for the new USPTO 101 guidance is over

The USPTO has finally released its new examination guidance on subject matter eligibility under Section 101, with the Office saying it “provides more detail” than its initial Alice guidance and is “a significant change” from its Myriad and Mayo guidance

uspto.jpg

The USPTO revealed its 59-page interim guidance today. It will be published on the Federal Register here on December 16. In the meantime, a pre-publication PDF can be downloaded here.

In a blog post, USPTO Commissioner for Patents Peggy Focarino said: “This guidance is the latest – but not necessarily the last – iteration of our ongoing implementation of these Supreme Court decisions,” wrote Focarino.


Claim examples have been developed to illustrate the analysis set forth in the guidance. A set of examples relating to nature-based products are posted on the USPTO website and a set of examples relating to abstract ideas will be released soon.

Focarino went on to address two aspects of the new guidance.

“First, the guidance explains the USPTO's interpretation of subject matter eligibility requirements in view of the Alice Corp, Myriad, and Mayo Supreme Court decisions and sets forth an integrated approach for patent examiners in making determinations regarding subject matter eligibility. This guidance incorporates principles emphasized in Alice Corp and provides more details than our initial examination instructions issued immediately after the Alice Corp decision.

peggy20focarino-150.jpg

“The guidance reflects a significant change from the examination guidance previously issued in response to Myriad and Mayo” – USPTO Commissioner for Patents Peggy Focarino

“Second, the guidance reflects a significant change from the examination guidance previously issued in response to Myriad and Mayo. The changes were triggered by the feedback we solicited and received from the public, as well as refinements necessitated by the Alice Corp decision.”

The USPTO’s previous guidance on the Supreme Court’s Alice, Myriad and Mayo decisions was received badly, with many thinking the Office was too strong in its reaction. As we reported in a recent article assessing how patent prosecution had been affected by the Alice decision, the initial Alice guidance released in June led to the USPTO withdrawing allowances for hundreds of applications.

For example, DLA Piper partner Dale Lazar told us: “They came out with initial guidelines concerning Alice and there was a fair amount of unanimity that those guidelines were no good. The Patent Office got that message.”

If anything, the reaction to the USPTO’s Myriad and Mayo guidance issued in March was even stronger. For example, Sherry Knowles described it as “horrifying”, and outlined concerns that it meant no natural product is patentable in the United States as a result, and maybe no derivative of natural products either.

In her blog post, Focarino said: “We carefully considered input from the public and our own patent examiners in addressing possible revisions both to our guidance stemming from Myriad and Mayo as well as Alice Corp. That led us to make changes to our analysis of subject matter eligibility under § 101, now set forth in the 2014 Interim Eligibility Guidance. We crafted this guidance to be a more straightforward eligibility analysis, one that promotes examination efficiency and consistency while conforming with the principles in the Supreme Court decisions.”

Once you have had a chance to digest the new guidance, let us know what you think, by either commenting on this blog post or joining the discussion on our LinkedIn group.

more from across site and ros bottom lb

More from across our site

Each week Managing IP speaks to a different IP lawyer about their life and career
Ireland joining the UPC would offer plenty of opportunities to local attorneys but there are fears that upcoming referendum could get ‘lost in the noise’
Attorneys at four firms reveal the business opportunities that stem from patent licensing agreements in the life sciences sector
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Counsel at four firms explain their lateral hiring policies and how they retain existing lawyers
Lori Gordon, who has joined from Perkins Coie, says she hopes to turn Goodwin into a 'premier' destination for PTAB work
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 EMEA Awards.
Partners at LeanWill Law Firm, a newly launched domestic firm in China, discuss IP opportunities and which clients they plan to target
Each week Managing IP speaks to a different IP lawyer about their life and career
A survey of more than 25,000 in-house lawyers reveals that embracing technology could help law firms win new business
Gift this article